All treatments
Treatment
Pneumovax® 23 solution for injection in pre-filled syringe Pneumococcal Polysaccharide Vaccine clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Children and Adolescents With Increased Risk of Pneumococcal Disease.
This study is testing a new vaccine (V116) to see how well it works and if it's safe for children and teens who are more likely to get sick from certain bacteria called pneumococcus. It compares the new vaccine to existing ones.
For: Pneumococcal diseaseSweden · Poland · France - Ongoing, recruitingTherapeutic use (Phase IV)
Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial
This study is looking at the best time of day for people aged 60-85 to have their flu jab. We want to see if getting the vaccine at a certain time helps your body create more protection against the flu virus.
For: InfluenzaNetherlands